Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production

Autor: Jildou Hoekstra, Terry G J Derks, Julius F. W. Baller, D. Margriet Ouwens, Folkert Kuipers, Rick Havinga, Louis M. Havekes, Aldo Grefhorst, Johannes A. Romijn
Přispěvatelé: Other departments, Center for Liver, Digestive and Metabolic Diseases (CLDM)
Jazyk: angličtina
Rok vydání: 2005
Předmět:
Male
Very low-density lipoprotein
Physiology
medicine.medical_treatment
Cholesterol
VLDL

chemistry.chemical_compound
Mice
Phosphatidylinositol 3-Kinases
tetradecylglycidic acid
Insulin
Beta oxidation
triglycerides
Fatty liver
Fatty Acids
Gastroenterology
Acute Disease
VLDL PRODUCTION
SHORT-TERM
SECRETION
carnitine palmitoyl transferase-1
FATTY-ACIDS
Oxidation-Reduction
medicine.medical_specialty
APOLIPOPROTEIN-B
Biology
METABOLISM
Protein Serine-Threonine Kinases
Insulin resistance
Physiology (medical)
Internal medicine
Proto-Oncogene Proteins
medicine
Animals
Hypoglycemic Agents
Liver X receptor
DE-NOVO LIPOGENESIS
Hepatology
RAT HEPATOCYTES
Cholesterol
medicine.disease
Acute hepatic steatosis
Fatty Liver
Mice
Inbred C57BL

Endocrinology
chemistry
Epoxy Compounds
2-TETRADECYLGLYCIDIC ACID
Insulin Resistance
LIVER-X-RECEPTOR
Proto-Oncogene Proteins c-akt
Zdroj: American journal of physiology. Gastrointestinal and liver physiology, 289(3), G592-G598. American Physiological Society
American Journal of Physiology-Gastrointestinal and Liver Physiology, 289(3), G592-G598. AMER PHYSIOLOGICAL SOC
ISSN: 0193-1857
DOI: 10.1152/ajpgi.00063.2005
Popis: Accumulation of triglycerides (TG) in the liver is generally associated with hepatic insulin resistance. We questioned whether acute hepatic steatosis induced by pharmacological blockade of beta-oxidation affects hepatic insulin sensitivity, i.e., insulin-mediated suppression of VLDL production and insulin-induced activation of phosphatidylinositol 3-kinase (PI3-kinase) and PKB. Tetradecylglycidic acid (TDGA), an inhibitor of carnitine palmitoyl transferase-1 (CPT1), was used for this purpose. Male C57BL/6J mice received 30 mg/kg TDGA or its solvent intraperitoneally and were subsequently fasted for 12 h. CPT1 inhibition resulted in severe microvesicular hepatic steatosis (19.9 +/- 8.3 vs. 112.4 +/- 25.2 nmol TG/mg liver, control vs. treated, P
Databáze: OpenAIRE